Td Asset Management Inc Argenx Se Transaction History

Td Asset Management Inc

  • $106 Billion
  • Q4 2024

A detailed history of Td Asset Management Inc transactions in Argenx Se stock. As of the latest transaction made, Td Asset Management Inc holds 172,681 shares of ARGX stock, worth $102 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
172,681
Previous 180,670 4.42%
Holding current value
$102 Million
Previous $98 Million 8.38%
% of portfolio
0.1%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$520.52 - $638.33 $4.16 Million - $5.1 Million
-7,989 Reduced 4.42%
172,681 $106 Million
Q3 2024

Nov 01, 2024
SELL
$434.22 - $551.9 $13.7 Million - $17.4 Million
-31,458 Reduced 14.83%
180,670 $98 Million
Q2 2024

Aug 02, 2024
SELL
$356.01 - $451.55 $4.12 Million - $5.22 Million
-11,567 Reduced 5.17%
212,128 $91.2 Million
Q1 2024

May 08, 2024
BUY
$356.95 - $413.29 $10.6 Million - $12.3 Million
29,810 Added 15.38%
223,695 $88.1 Million
Q4 2023

Feb 12, 2024
BUY
$338.91 - $506.01 $6.27 Million - $9.37 Million
18,514 Added 10.56%
193,885 $73.8 Million
Q3 2023

Oct 27, 2023
BUY
$369.35 - $548.43 $19.1 Million - $28.4 Million
51,791 Added 41.91%
175,371 $86.2 Million
Q2 2023

Aug 09, 2023
BUY
$360.14 - $422.58 $2.34 Million - $2.75 Million
6,510 Added 5.56%
123,580 $48.2 Million
Q1 2023

May 10, 2023
SELL
$334.23 - $403.65 $4.01 Million - $4.84 Million
-12,000 Reduced 9.3%
117,070 $43.6 Million
Q4 2022

Feb 06, 2023
SELL
$342.17 - $402.31 $22.7 Million - $26.7 Million
-66,327 Reduced 33.94%
129,070 $48.9 Million
Q3 2022

Nov 07, 2022
SELL
$343.2 - $395.75 $2.61 Million - $3.01 Million
-7,618 Reduced 3.75%
195,397 $69.9 Million
Q2 2022

Aug 04, 2022
SELL
$269.58 - $378.88 $1.86 Million - $2.61 Million
-6,890 Reduced 3.28%
203,015 $76.9 Million
Q1 2022

May 10, 2022
BUY
$254.45 - $351.06 $2.3 Million - $3.17 Million
9,027 Added 4.49%
209,905 $66.2 Million
Q4 2021

Feb 10, 2022
BUY
$272.01 - $353.03 $17.7 Million - $23 Million
65,117 Added 47.96%
200,878 $70.3 Million
Q3 2021

Nov 09, 2021
BUY
$295.0 - $350.58 $926,300 - $1.1 Million
3,140 Added 2.37%
135,761 $41 Million
Q2 2021

Aug 11, 2021
SELL
$257.11 - $319.92 $1.21 Million - $1.51 Million
-4,716 Reduced 3.43%
132,621 $40.4 Million
Q1 2021

May 14, 2021
BUY
$268.3 - $380.31 $4.52 Million - $6.41 Million
16,854 Added 13.99%
137,337 $37.8 Million
Q4 2020

Feb 16, 2021
BUY
$248.13 - $308.36 $1.52 Million - $1.89 Million
6,128 Added 5.36%
120,483 $35.4 Million
Q3 2020

Nov 10, 2020
BUY
$215.51 - $272.51 $457,743 - $578,811
2,124 Added 1.89%
114,355 $30 Million
Q2 2020

Aug 13, 2020
BUY
$127.44 - $232.72 $3.48 Million - $6.36 Million
27,324 Added 32.18%
112,231 $25.3 Million
Q1 2020

May 15, 2020
SELL
$108.83 - $165.23 $761,810 - $1.16 Million
-7,000 Reduced 7.62%
84,907 $11.2 Million
Q4 2019

Feb 11, 2020
BUY
$106.59 - $164.21 $149,226 - $229,894
1,400 Added 1.55%
91,907 $14.8 Million
Q3 2019

Nov 07, 2019
BUY
$113.31 - $150.51 $305,937 - $406,377
2,700 Added 3.07%
90,507 $10.3 Million
Q2 2019

Aug 01, 2019
BUY
$115.0 - $141.58 $545,905 - $672,080
4,747 Added 5.72%
87,807 $12.4 Million
Q1 2019

May 08, 2019
BUY
$98.85 - $134.59 $3.27 Million - $4.45 Million
33,082 Added 66.19%
83,060 $10.4 Million
Q4 2018

Feb 01, 2019
BUY
$63.81 - $109.82 $223,335 - $384,370
3,500 Added 7.53%
49,978 $4.8 Million
Q3 2018

Nov 01, 2018
BUY
$75.5 - $96.63 $577,273 - $738,832
7,646 Added 19.69%
46,478 $3.53 Million
Q2 2018

Jul 31, 2018
BUY
$74.84 - $100.16 $220,927 - $295,672
2,952 Added 8.23%
38,832 $3.22 Million
Q1 2018

May 11, 2018
BUY
$56.95 - $85.19 $1.1 Million - $1.64 Million
19,255 Added 115.82%
35,880 $2.89 Million
Q4 2017

Feb 02, 2018
BUY
$22.57 - $63.56 $375,226 - $1.06 Million
16,625
16,625 $1.05 Million

Others Institutions Holding ARGX

# of Institutions
434
Shares Held
28.8M
Call Options Held
390K
Put Options Held
272K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $32.7B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email